期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
自体心包管肺动脉移植在晚期肺癌外科治疗中的临床应用
1
作者 罗东 付向宁 张良华 《华中医学杂志》 2004年第4期243-244,共2页
目的 探讨自体心包管肺动脉移植在晚期肺癌外科治疗中的手术技巧和疗效。方法 对 8例Ⅲb期肺动脉干严重受累的肺癌患者采用自体心包管肺动脉移植术。结果 全组病例无手术死亡 ,肿瘤完整切除 ,术侧余肺血供良好 ,8例患者均临床痊愈。... 目的 探讨自体心包管肺动脉移植在晚期肺癌外科治疗中的手术技巧和疗效。方法 对 8例Ⅲb期肺动脉干严重受累的肺癌患者采用自体心包管肺动脉移植术。结果 全组病例无手术死亡 ,肿瘤完整切除 ,术侧余肺血供良好 ,8例患者均临床痊愈。结论 自体心包管肺动脉移植避免了全肺切除 。 展开更多
关键词 自体心包管肺动脉移植 晚期肺癌 外科治疗 手术方法
下载PDF
ⅢB期肺动脉干严重受累肺癌行自体心包管肺动脉移植术的可行性及有效性研究 被引量:1
2
作者 赵振兴 郭岩 +3 位作者 赵振山 李海洋 代岱 郝孟辉 《中华肿瘤防治杂志》 CAS 北大核心 2015年第B11期104-105,共2页
目的分析ⅢB期肺动脉干严重受累肺癌行自体心包管肺动脉移植术的可行性及有效性。方法随机选取2011-01-2015-01开滦总医院收治的50例ⅢB期肺动脉干严重受累肺癌患者,并且依据治疗方法的不同,分为研究组(25例)和对照组(25例)。对... 目的分析ⅢB期肺动脉干严重受累肺癌行自体心包管肺动脉移植术的可行性及有效性。方法随机选取2011-01-2015-01开滦总医院收治的50例ⅢB期肺动脉干严重受累肺癌患者,并且依据治疗方法的不同,分为研究组(25例)和对照组(25例)。对照组患者应用常规手术治疗,研究组患者采取自体心包管肺动脉移植术,对比两组患者临床手术可行性及有效性。结果研究组中患者,临床经自体心包管肺动脉移植术治疗后,患者临床疗效好,研究组治疗有效性显著高于对照组,两组对比差异有统计学意义,P〈0.05。结论在临床治疗ⅢB期肺动脉干严重受累肺癌中,应用自体心包管肺动脉移植术治疗,不仅提升临床手术疗效,有效性高,具有可行性,发挥积极手术疗效。 展开更多
关键词 有效性 IIIB期肺动脉干严重受累肺癌 可行性 自体心包管肺动脉移植术
原文传递
自体心包管作冠脉搭桥旁路移植血管研究
3
作者 周虎平 沈远仲 《中华实验外科杂志》 CAS CSCD 北大核心 1990年第3期122-123,共2页
关键词 血管移植 冠脉搭桥 心包管
原文传递
自体心包片下腔静脉重建
4
作者 徐忠立 《肝胆外科杂志》 2003年第3期200-202,共3页
目的 探讨自体心包片腔静脉成形 (APPC)或下腔静脉重建 (RIVC)的治疗方法、适应症、临床价值和注意事项。方法 自 1 986年 5月至 1 998年 6月我们完成了 APPC治疗下腔静脉 (IVC) -肝静脉 (HV)狭窄 39例和自体心包管代血管IVC移植 (VTI... 目的 探讨自体心包片腔静脉成形 (APPC)或下腔静脉重建 (RIVC)的治疗方法、适应症、临床价值和注意事项。方法 自 1 986年 5月至 1 998年 6月我们完成了 APPC治疗下腔静脉 (IVC) -肝静脉 (HV)狭窄 39例和自体心包管代血管IVC移植 (VTIVC)治疗 IVC闭塞或缺损 3例 ,同时施行直视根治术切除梗阻病灶。结果 手术死亡 2例 (死亡率 4 .76 % ) ,1例死于肝肾综合征 ,另 1例死于呼吸道出血性窒息。 4 0例痊愈出院 (治愈率 95 .2 4 % )。术后随访 1 3~ 96个月 ,37例典型症状体征消失 ,B超和 IVC造影证实 IVC- HV通畅良好者 37例 ,术后 1 .5年显示 IVC狭窄 1例 ,2例于术后 2~ 4个月发现 IVC血栓形成。结论  APPC是治疗 IVC- HV狭窄或闭塞的直接有效的外科疗法 。 展开更多
关键词 下腔静脉 肝静脉 狭窄 闭塞治疗 包片 心包管 腔静脉成形 血管移植
下载PDF
Clinical observation on pericardial effusion in patients with lung cancer treated by intrapericardial catheterization and infusion of highly agglutinative staphylococcin and cisplatin 被引量:3
5
作者 Qi'an Jiang Yide Zhou Gui'e Cheng Fangyun Gong Shuyan Zhang Fengping Lang Meihong Zhao 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第5期316-318,共3页
Objective: To evaluate the therapeutic efficacy of injecting highly agglutinative staphylococcin (HASL) and cisplatin into pericardial cavity of lung cancer patients with pericardial effusion. Methods: 81 patients wer... Objective: To evaluate the therapeutic efficacy of injecting highly agglutinative staphylococcin (HASL) and cisplatin into pericardial cavity of lung cancer patients with pericardial effusion. Methods: 81 patients were randomized into two groups: 45 in the experimental group (HASL and Cisplatin) and 36 in the control group (Cisplatin). At first pericardial effusion was drained out from a intrapericardial catheter and then different drugs were infused, respectively. 24 h after perfusion the draining continued again until drainage quantity was less than 30 mL every day. The draining lasted 10–15 days. Results: The response rate was 91.1% for the experimental group and 80.6% for the control group. There was no significant difference between the two groups (P>0.05). The complete remission was 77.8% for the experimental group and 52.8% for the control group, which was statistically significant difference (P<0.05). The adverse effects were myelosuppression and nausea and vomiting, which were 35.6% and 40.0% in the experimental group and 72.2% and 66.7% in the control group, respectively (P<0.01, P<0.05). Conclusion: Inject- ing HASL and cisplatin into pericardial cavity may be a better way to control pericardial effusion of lung cancer. 展开更多
关键词 pericardial effusion lung cancer highly agglutinative staphylococcin
下载PDF
REGULATING EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ANG Ⅱ ON FROG'S PERICARDIAL STOMATA, MESOTHELIUM AND ANGIOGENESIS 被引量:1
6
作者 李继承 周吉林 +2 位作者 BrunoTota GiusyScalia AlfonsinaGattuso 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第1期23-28,共6页
To observe the regulating effects of vascular endothelial growth factor (VEGF) and angiotensinⅡ (ANG II) on the frog’s pericardium, lymphatic stomata and angiogenesis so as to reveal their effects and mechanism on t... To observe the regulating effects of vascular endothelial growth factor (VEGF) and angiotensinⅡ (ANG II) on the frog’s pericardium, lymphatic stomata and angiogenesis so as to reveal their effects and mechanism on the mesothelial permeability, lymphatic stoma regulation and myocardial hypertrophy. Methods. VEGF and ANGⅡ were injected into the frog’s peritoneal cavity so as to examine the changes of the pericardial stromata by using transmission electron microscopy, scanning electron microscopy and computerized imaging analysis. Results. Scattered distributed pericardial stomata were found on the parietal pericardium of the frog with a few sinusoid mesothelial cells, whose blood supply was directly from the cardiac chambers flowing into the trabecular spaces of the myocardium (because there are no blood vessels in the myocardium of the frog). The average diameters of the pericardial stomata in VEGF and ANGⅡ groups were 1.50μ m and 1.79μ m respectively, which were much larger than those in the control group (0.72μ m, P Conclusions. VEGF and ANGⅡ could strongly regulate the pericardial stomata by increasing their numbers and openings with larger diameters and higher distribution density. They could also increase the sinusoid areas with the result of the higher permeability of the pericardium, which clearly indicated that VEGF and ANGⅡ could speed up the material transfer of the pericardial cavity and play an important role in preventing myocardial interstitial edema. Yet there was no strong evidence to show the angiogenesis in the myocardium. 展开更多
关键词 vascular endothelial growth factor angioteinsin II lymphatic stomata
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部